PRME: FDA Grants Designation
Prime Medicine says FDA grants regenerative medicine advanced therapy designation to PM359 for treatment of p47phox-deficient CGD
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.